Medicinálny Oxid Dusný Siad (Nitrous Oxide)

Nitrous oxide acts mainly by blocking NMDA receptors in the central nervous system, reducing excitatory neurotransmission that conveys pain signals. It also modulates opioid pathways and catecholamine release, producing a combined effect of analgesia and mild sedation.

The specific dose and concentration of nitrous oxide are determined by the prescribing clinician based on the procedure, patient age, weight, and medical condition. The prescriber sets the appropriate delivery parameters and monitors the patient throughout the treatment.

Safety data for nitrous oxide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use should be considered only when clearly needed and after evaluating potential risks and benefits with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with intravenous opioids, nitrous oxide offers rapid onset, easy titration, and quick recovery without the need for injection. Unlike volatile anesthetic gases, it is administered at low concentrations for analgesia rather than deep anesthesia, making it suitable for short, minimally invasive procedures.

Store the nitrous oxide cylinders at ambient temperature, preferably below 25 °C, in an upright position. Keep them in the original packaging, protect from direct sunlight, heat sources and moisture, and ensure the area is well‑ventilated to prevent gas accumulation.

The product is delivered as a medical gas through a nasal mask or nasal cannula. The prescriber adjusts the flow rate to achieve the desired concentration, and the patient inhales the gas while continuous monitoring of oxygen saturation and respiratory status is maintained.

Serious risks include hypoxia, loss of consciousness, severe respiratory depression, and rare allergic reactions. These events are uncommon when the gas is administered with proper monitoring and supplemental oxygen, but immediate medical intervention is required if they occur.

Patients with severe chronic obstructive pulmonary disease, untreated pneumothorax, known hypersensitivity to nitrous oxide, or those who cannot tolerate nasal masks should avoid its use. Additionally, individuals with certain vitamin B12 deficiencies may be at risk for adverse metabolic effects.